Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Abuse, Drug
  • Pain
Type
Interventional
Phase
Phase 1
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.Masking: Double (Participant, Investigator)Primary Purpose: Basic Science

Participation Requirements

Age
Between 21 years and 55 years
Gender
Both males and females

Description

The proposed study will compare smoked cannabis's dose-dependent, analgesic and abuse-related effects between men and women and variables that underlie these sex-dependent differences, including pharmacokinetics of THC.

The proposed study will compare smoked cannabis's dose-dependent, analgesic and abuse-related effects between men and women and variables that underlie these sex-dependent differences, including pharmacokinetics of THC.

Tracking Information

NCT #
NCT04385082
Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Ziva Cooper, PhD University of California, Los Angeles